| Attribute |
Value |
| 52 Week Change |
0.18726587 |
| Address1 |
Dr. Neergaards Vej |
| Address2 |
5th Floor |
| All Time High |
1,252.0 |
| All Time Low |
1.2 |
| Ask |
3.9 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
21,310 |
| Average Daily Volume3 Month |
30,265 |
| Average Volume |
30,265 |
| Average Volume10Days |
21,310 |
| Beta |
0.263 |
| Bid |
2.31 |
| Bid Size |
2 |
| Book Value |
1.584 |
| City |
Horsholm |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Denmark |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
3.02 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
3.22 |
| Day Low |
3.02 |
| Earnings Call Timestamp End |
1,748,349,000 |
| Earnings Call Timestamp Start |
1,748,349,000 |
| Earnings Timestamp End |
1,755,520,200 |
| Earnings Timestamp Start |
1,755,001,800 |
| Ebitda |
-8,824,500 |
| Ebitda Margins |
-1.17222 |
| Enterprise To Ebitda |
-0.765 |
| Enterprise To Revenue |
0.896 |
| Enterprise Value |
6,747,449 |
| Eps Current Year |
-0.04 |
| Eps Forward |
0.04 |
| Eps Trailing Twelve Months |
-0.96 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
3.7613 |
| Fifty Day Average Change |
-0.7413001 |
| Fifty Day Average Change Percent |
-0.19708614 |
| Fifty Two Week Change Percent |
18.726587 |
| Fifty Two Week High |
12.15 |
| Fifty Two Week High Change |
-9.129999 |
| Fifty Two Week High Change Percent |
-0.7514403 |
| Fifty Two Week Low |
2.45 |
| Fifty Two Week Low Change |
0.56999993 |
| Fifty Two Week Low Change Percent |
0.23265304 |
| Fifty Two Week Range |
2.45 - 12.15 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,612,535,400,000 |
| Float Shares |
5,679,353 |
| Forward Eps |
0.04 |
| Forward P E |
75.5 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
46 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
1.0 |
| Gross Profits |
7,528,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.17469 |
| Held Percent Institutions |
0.09401 |
| Implied Shares Outstanding |
8,340,215 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-02-05 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,736,812,800 |
| Last Split Factor |
1:5 |
| Long Business Summary |
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark. |
| Long Name |
Evaxion A/S |
| Market |
us_market |
| Market Cap |
25,187,450 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_319014926 |
| Most Recent Quarter |
1,774,915,200 |
| Name Change Date |
2,026-07-13 |
| Net Income To Common |
-9,756,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
26,438,481 |
| Number Of Analyst Opinions |
4 |
| Open |
3.22 |
| Operating Margins |
-1.22011 |
| Payout Ratio |
0.0 |
| Phone |
45 53 53 18 50 |
| Prev Name |
Evaxion Biotech A/S |
| Previous Close |
3.17 |
| Price Eps Current Year |
-75.5 |
| Price Hint |
4 |
| Price To Book |
1.9065657 |
| Price To Sales Trailing12 Months |
3.3458354 |
| Profit Margins |
-1.29596 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.15 |
| Regular Market Change Percent |
-4.73186 |
| Regular Market Day High |
3.22 |
| Regular Market Day Low |
3.02 |
| Regular Market Day Range |
3.02 - 3.22 |
| Regular Market Open |
3.22 |
| Regular Market Previous Close |
3.17 |
| Regular Market Price |
3.02 |
| Regular Market Time |
1,783,972,800 |
| Regular Market Volume |
14,523 |
| Return On Assets |
-0.23488002 |
| Return On Equity |
-0.82931 |
| Revenue Per Share |
1.059 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
8,340,215 |
| Shares Percent Shares Out |
0.0034999999 |
| Shares Short |
29,391 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
24,851 |
| Short Name |
Evaxion A/S |
| Short Percent Of Float |
0.0043 |
| Short Ratio |
0.94 |
| Source Interval |
15 |
| Symbol |
EVAX |
| Target High Price |
16.0 |
| Target Low Price |
9.0 |
| Target Mean Price |
11.25 |
| Target Median Price |
10.0 |
| Total Cash |
18,440,000 |
| Total Cash Per Share |
2.211 |
| Total Debt |
0 |
| Total Revenue |
7,528,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.96 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
4.486375 |
| Two Hundred Day Average Change |
-1.4663749 |
| Two Hundred Day Average Change Percent |
-0.3268507 |
| Type Disp |
Equity |
| Volume |
14,523 |
| Website |
https://evaxion.ai |
| Zip |
2,970 |